Study protocol for Vitality: a proof-of-concept randomised controlled trial of exercise training or complex mental and social activities to promote cognition in adults with chronic stroke

John R Best, Janice J Eng, Jennifer C Davis, Robin Hsiung, Peter A Hall, Laura E Middleton, Peter Graf, Charles H Goldsmith, Teresa Liu-Ambrose, John R Best, Janice J Eng, Jennifer C Davis, Robin Hsiung, Peter A Hall, Laura E Middleton, Peter Graf, Charles H Goldsmith, Teresa Liu-Ambrose

Abstract

Introduction: Cerebrovascular disease-such as stroke-is the second most common cause of dementia (ie, vascular dementia). Specifically, a stroke increases one's risk for dementia by a factor of two. Thus, stroke survivors represent a target population in need of intervention strategies to promote cognitive function and prevent dementia. The current standard of care in stroke rehabilitation does not adequately address the significant cognitive consequences of stroke, especially for those who are in the chronic phase (ie, >12 months since an index stroke). Two potential intervention strategies are: (1) exercise training and (2) cognitive and social enrichment activities.

Methods and analysis: The aim of this proof-of-concept randomised controlled trial is to determine whether a 6-month targeted exercise training programme or a 6-month cognitive and social enrichment programme can efficaciously and efficiently improve cognitive function in older adults with chronic stroke compared with a 6-month stretch and tone programme (ie, control). The primary measurement periods will be baseline, month 6 (postintervention) and month 12 (6-month follow-up). The primary outcome measure will be performance on the Alzheimer's Disease Assessment Scale-Cognitive-Plus (ADAS-Cog-Plus), a global measure of cognitive performance using multidimensional item response theory to summarise scores from the 13-item ADAS-Cog and other standard cognitive assessments. The primary analysis will compare changes in ADAS-Cog-Plus performance from baseline to month 6. Proof-of-concept outcomes relating to intervention feasibility will be analysed descriptively. The economic evaluation will examine the incremental costs and health outcome benefits generated by both interventions versus the control.

Ethics and dissemination: Ethical approval has been obtained from the University of British Columbia's Clinical Research Ethics Board (H13-00715, 26 July 2013). Any modifications to the protocol will require a formal amendment to the protocol and approval by the Research Ethics Board. Outcomes of this randomised controlled trial and the statistical code to generate those outcomes will be disseminated through publication in peer-reviewed journals as well as conference presentations.

Trial registration number: NCT01916486.

Keywords: chronic stroke; cognitive function; cognitive training; exercise.

Conflict of interest statement

Competing interests: None declared.

© Article author(s) (or their employer(s) unless otherwise stated in the text of the article) 2018. All rights reserved. No commercial use is permitted unless otherwise expressly granted.

Figures

Figure 1
Figure 1
Overview of the flow of participants through from recruitment to study completion. Cog-Plus, Cognitive-Plus.

References

    1. Seshadri S, Beiser A, Kelly-Hayes M, et al. . The lifetime risk of stroke: estimates from the Framingham Study. Stroke 2006;37:345–50. 10.1161/01.STR.0000199613.38911.b2
    1. Rockwood K, Wentzel C, Hachinski V, et al. . Prevalence and outcomes of vascular cognitive impairment. Vascular cognitive impairment investigators of the Canadian study of health and aging. Neurology 2000;54:447–51.
    1. Desmond DW, Erkinjuntti T, Sano M, et al. . The cognitive syndrome of vascular dementia: implications for clinical trials. Alzheimer Dis Assoc Disord 1999;13(Suppl 3):S21–9.
    1. Erkinjuntti T, Bowler JV, DeCarli CS, et al. . Imaging of static brain lesions in vascular dementia: implications for clinical trials. Alzheimer Dis Assoc Disord 1999;13(Suppl 3):S81–90.
    1. Pantoni L, Leys D, Fazekas F, et al. . Role of white matter lesions in cognitive impairment of vascular origin. Alzheimer Dis Assoc Disord 1999;13(Suppl 3):S49–54.
    1. Fratiglioni L, De Ronchi D, Agüero-Torres H. Worldwide prevalence and incidence of dementia. Drugs Aging 1999;15:365–75. 10.2165/00002512-199915050-00004
    1. Kokmen E, Whisnant JP, O’Fallon WM, et al. . Dementia after ischemic stroke: a population-based study in Rochester, Minnesota (1960-1984). Neurology 1996;46:154–9. 10.1212/WNL.46.1.154
    1. Zinn S, Bosworth HB, Hoenig HM, et al. . Executive function deficits in acute stroke. Arch Phys Med Rehabil 2007;88:173–80. 10.1016/j.apmr.2006.11.015
    1. Tatemichi TK, Desmond DW, Stern Y, et al. . Cognitive impairment after stroke: frequency, patterns, and relationship to functional abilities. J Neurol Neurosurg Psychiatry 1994;57:202–7. 10.1136/jnnp.57.2.202
    1. Sun JH, Tan L, Yu JT. Post-stroke cognitive impairment: epidemiology, mechanisms and management. Ann Transl Med 2014;2:80 10.3978/j.issn.2305-5839.2014.08.05
    1. Pasquini M, Leys D, Rousseaux M, et al. . Influence of cognitive impairment on the institutionalisation rate 3 years after a stroke. J Neurol Neurosurg Psychiatry 2007;78:56–9. 10.1136/jnnp.2006.102533
    1. Edwards JD, Koehoorn M, Boyd LA, et al. . Is health-related quality of life improving after stroke? A comparison of health utilities indices among Canadians with stroke between 1996 and 2005. Stroke 2010;41:996–1000. 10.1161/STROKEAHA.109.576678
    1. Patel MD, Coshall C, Rudd AG, et al. . Cognitive impairment after stroke: clinical determinants and its associations with long-term stroke outcomes. J Am Geriatr Soc 2002;50:700–6. 10.1046/j.1532-5415.2002.50165.x
    1. Heyn P, Abreu BC, Ottenbacher KJ. The effects of exercise training on elderly persons with cognitive impairment and dementia: a meta-analysis. Arch Phys Med Rehabil 2004;85:1694–704.
    1. Colcombe S, Kramer AF. Fitness effects on the cognitive function of older adults: a meta-analytic study. Psychol Sci 2003;14:125–30. 10.1111/1467-9280.t01-1-01430
    1. Etnier JL, Nowell PM, Landers DM, et al. . A meta-regression to examine the relationship between aerobic fitness and cognitive performance. Brain Res Rev 2006;52:119–30. 10.1016/j.brainresrev.2006.01.002
    1. Lautenschlager NT, Cox KL, Flicker L, et al. . Effect of physical activity on cognitive function in older adults at risk for Alzheimer disease: a randomized trial. JAMA 2008;300:1027–37. 10.1001/jama.300.9.1027
    1. Baker LD, Frank LL, Foster-Schubert K, et al. . Effects of aerobic exercise on mild cognitive impairment: a controlled trial. Arch Neurol 2010;67:71–9. 10.1001/archneurol.2009.307
    1. Liu-Ambrose T, Nagamatsu LS, Graf P, et al. . Resistance training and executive functions: a 12-month randomized controlled trial. Arch Intern Med 2010;170:170–8. 10.1001/archinternmed.2009.494
    1. Liu-Ambrose T, Nagamatsu LS, Voss MW, et al. . Resistance training and functional plasticity of the aging brain: a 12-month randomized controlled trial. Neurobiol Aging 2012;33:1690–8. 10.1016/j.neurobiolaging.2011.05.010
    1. Voss MW, Vivar C, Kramer AF, et al. . Bridging animal and human models of exercise-induced brain plasticity. Trends Cogn Sci 2013;17:525–44. 10.1016/j.tics.2013.08.001
    1. Cotman CW, Berchtold NC, Christie LA. Exercise builds brain health: key roles of growth factor cascades and inflammation. Trends Neurosci 2007;30:464–72. 10.1016/j.tins.2007.06.011
    1. Mason JL, Ye P, Suzuki K, et al. . Insulin-like growth factor-1 inhibits mature oligodendrocyte apoptosis during primary demyelination. J Neurosci 2000;20:5703–8.
    1. Ye P, Carson J, D’Ercole AJ. In vivo actions of insulin-like growth factor-I (IGF-I) on brain myelination: studies of IGF-I and IGF binding protein-1 (IGFBP-1) transgenic mice. J Neurosci 1995;15:7344–56.
    1. Cumming TB, Tyedin K, Churilov L, et al. . The effect of physical activity on cognitive function after stroke: a systematic review. Int Psychogeriatr 2012;24:557–67. 10.1017/S1041610211001980
    1. McDonnell MN, Smith AE, Mackintosh SF. Aerobic exercise to improve cognitive function in adults with neurological disorders: a systematic review. Arch Phys Med Rehabil 2011;92:1044–52. 10.1016/j.apmr.2011.01.021
    1. Rand D, Eng JJ, Liu-Ambrose T, et al. . Feasibility of a 6-month exercise and recreation program to improve executive functioning and memory in individuals with chronic stroke. Neurorehabil Neural Repair 2010;24:722–9. 10.1177/1545968310368684
    1. Quaney BM, Boyd LA, McDowd JM, et al. . Aerobic exercise improves cognition and motor function poststroke. Neurorehabil Neural Repair 2009;23:879–85. 10.1177/1545968309338193
    1. Moore SA, Hallsworth K, Jakovljevic DG, et al. . Effects of community exercise therapy on metabolic, brain, physical, and cognitive function following stroke: a randomized controlled pilot trial. Neurorehabil Neural Repair 2015;29:623–35. 10.1177/1545968314562116
    1. Marzolini S, Oh P, McIlroy W, et al. . The effects of an aerobic and resistance exercise training program on cognition following stroke. Neurorehabil Neural Repair 2013;27:392–402. 10.1177/1545968312465192
    1. Tang A, Eng JJ, Krassioukov AV, et al. . High- and low-intensity exercise do not improve cognitive function after stroke: A randomized controlled trial. J Rehabil Med 2016;48:841–6. 10.2340/16501977-2163
    1. Löfgren B, Nyberg L, Mattsson M, et al. . Three years after in-patient stroke rehabilitation: a follow-up study. Cerebrovasc Dis 1999;9:163–70. 10.1159/000015948
    1. Robinson CA, Shumway-Cook A, Matsuda PN, et al. . Understanding physical factors associated with participation in community ambulation following stroke. Disabil Rehabil 2011;33:1033–42. 10.3109/09638288.2010.520803
    1. Morris J, Oliver T, Kroll T, et al. . The importance of psychological and social factors in influencing the uptake and maintenance of physical activity after stroke: a structured review of the empirical literature. Stroke Res Treat 2012;2012:1–20. 10.1155/2012/195249
    1. van Praag H, Kempermann G, Gage FH. Neural consequences of environmental enrichment. Nat Rev Neurosci 2000;1:191–8. 10.1038/35044558
    1. Liu-Ambrose T, Eng JJ. Exercise training and recreational activities to promote executive functions in chronic stroke: a proof-of-concept study. J Stroke Cerebrovasc Dis 2015;24:130–7. 10.1016/j.jstrokecerebrovasdis.2014.08.012
    1. Canadian Society for Exercise Physiology. Par-Q and you. Gloucester, Ontario, Canada: Canadian Society of Exercise Physiology, 1994:1–2.
    1. Folstein MF, Folstein SE, McHugh PR, et al. . "Mini-mental state". A practical method for grading the cognitive state of patients for the clinician. J Psychiatr Res 1975;12:189–98.
    1. Nasreddine ZS, Phillips NA, Bédirian V, et al. . The montreal cognitive assessment, moca: a brief screening tool for mild cognitive impairment. J Am Geriatr Soc 2005;53:695–9. 10.1111/j.1532-5415.2005.53221.x
    1. Kelly-Hayes M, Robertson JT, Broderick JP, et al. . The American Heart Association Stroke Outcome Classification: executive summary. Circulation 1998;97:2474–8. 10.1161/01.CIR.97.24.2474
    1. Granger CV. The emerging science of functional assessment: our tool for outcomes analysis. Arch Phys Med Rehabil 1998;79:235–40. 10.1016/S0003-9993(98)90000-4
    1. Groll DL, To T, Bombardier C, et al. . The development of a comorbidity index with physical function as the outcome. J Clin Epidemiol 2005;58:595–602. 10.1016/j.jclinepi.2004.10.018
    1. Mungas D, Crane P, Dowling M, et al. . Optimizing cognitive outcome measures in AD clinical trials: Technical Summary. 2013.
    1. Rosen WG, Mohs RC, Davis KL. A new rating scale for Alzheimer’s disease. Am J Psychiatry 1984;141:1356–64. 10.1176/ajp.141.11.1356
    1. Spreen O, Strauss E. A compendium of neurological tests. 2nd edn New York: Oxford University Press, Inc, 1998.
    1. Wechsler D. Wechsler adult intelligence scale - revised. New York: The Psychological Corporation, Harcourt Brace Jovanovich, 1981.
    1. Trenerry M, Crosson B, DeBoe J, et al. . Stroop Neuropsychological Screening Test: Psychological Assessment Resources. 1988.
    1. Lawton MP, Brody EM. Assessment of older people: self-maintaining and instrumental activities of daily living. Gerontologist 1969;9:179–86. 10.1093/geront/9.3_Part_1.179
    1. Guralnik JM, Ferrucci L, Simonsick EM, et al. . Lower-extremity function in persons over the age of 70 years as a predictor of subsequent disability. N Engl J Med 1995;332:556–62. 10.1056/NEJM199503023320902
    1. Lord SR, Menz HB, Tiedemann A. A physiological profile approach to falls risk assessment and prevention. Phys Ther 2003;83:237–52.
    1. Carod-Artal J, Egido JA, González JL, et al. . Quality of life among stroke survivors evaluated 1 year after stroke: experience of a stroke unit. Stroke 2000;31:2995–3000. 10.1161/01.STR.31.12.2995
    1. Berger AK, Fratiglioni L, Winblad B, et al. . Alzheimer’s disease and depression: preclinical comorbidity effects on cognitive functioning. Cortex 2005;41:603–12. 10.1016/S0010-9452(08)70200-4
    1. Radloff LS. The CES-D Scale: a self-report depression scale for research in the general population. Sage 1977;1:385–401.
    1. Ware J, Kosinski M, Keller SD. A 12-Item Short-Form Health Survey: construction of scales and preliminary tests of reliability and validity. Med Care 1996;34:220–33.
    1. Bohannon RW, Maljanian R, Lee N, et al. . Measurement properties of the short form (SF)-12 applied to patients with stroke. Int J Rehabil Res 2004;27:151–4. 10.1097/
    1. Validation of a new actigraph motion watch versus polysomnography on 70 healthy and suspected sleep-disordered subjects. J Sleep Res 2012.
    1. Middleton B, Hampton S. Comparison of new activity monitors (MW8) and PRO-Diary Motion (PDM) containing accelerometer with existing activity monitors (AWL). University of Surrey 2012:1–38.
    1. Stewart AL, Mills KM, King AC, et al. . CHAMPS physical activity questionnaire for older adults: outcomes for interventions. Med Sci Sports Exerc 2001;33:1126–41. 10.1097/00005768-200107000-00010
    1. Drummond AE, Parker CJ, Gladman JR, et al. . Development and validation of the Nottingham Leisure Questionnaire (NLQ). Clin Rehabil 2001;15:647–56. 10.1191/0269215501cr438oa
    1. Pang MY, Eng JJ, Dawson AS, et al. . A community-based fitness and mobility exercise program for older adults with chronic stroke: a randomized, controlled trial. J Am Geriatr Soc 2005;53:1667–74. 10.1111/j.1532-5415.2005.53521.x
    1. Eng JJ, Chu KS, Dawson AS, et al. . Functional walk tests in individuals with stroke: relation to perceived exertion and myocardial exertion. Stroke 2002;33:756–61. 10.1161/hs0302.104195
    1. Basak C, Boot WR, Voss MW, et al. . Can training in a real-time strategy video game attenuate cognitive decline in older adults? Psychol Aging 2008;23:765–77. 10.1037/a0013494
    1. Moritz R, Neeson I, Latif F, et al. . Perk activities: the social experience that stimulates. 2017. (accessed 6 Dec 2017).
    1. Liu-Ambrose T, Khan KM, Eng JJ, et al. . Resistance and agility training reduce fall risk in women aged 75 to 85 with low bone mass: a 6-month randomized, controlled trial. J Am Geriatr Soc 2004;52:657–65. 10.1111/j.1532-5415.2004.52200.x
    1. Shumway-Cook A, Brauer S, Woollacott M. Predicting the probability for falls in community-dwelling older adults using the Timed Up & Go Test. Phys Ther 2000;80:896–903.
    1. Hillsdon M, Foster C, Thorogood M. Interventions for promoting physical activity. Cochrane Database Syst Rev 2005;1:CD003180 10.1002/14651858.CD003180.pub2
    1. Sniehotta FF, Scholz U, Schwarzer R. Action plans and coping plans for physical exercise: A longitudinal intervention study in cardiac rehabilitation. Br J Health Psychol 2006;11(Pt 1):23–37. 10.1348/135910705X43804
    1. Gollwitzer PM, Sheeran P. Implementation intentions and goal achievement: a meta-analysis of effects and processes. Advances in Experimental Social Psychology 2006;38:69–119.
    1. Michie S, Abraham C, Whittington C, et al. . Effective techniques in healthy eating and physical activity interventions: a meta-regression. Health Psychol 2009;28:690–701. 10.1037/a0016136
    1. Hillsdon M, Foster C, Cavill N, et al. . The effectiveness of public health interventions for increasing physical activity among adults: a review of reviews. London: Health Development Agency, 2005:1–40.
    1. Orgogozo JM, Rigaud AS, Stöffler A, et al. . Efficacy and safety of memantine in patients with mild to moderate vascular dementia: a randomized, placebo-controlled trial (MMM 300). Stroke 2002;33:1834–9. 10.1161/01.STR.0000020094.08790.49
    1. Pratt RD, Perdomo CA. Donepezil-treated patients with probable vascular dementia demonstrate cognitive benefits. Ann N Y Acad Sci 2002;977:513–22. 10.1111/j.1749-6632.2002.tb04859.x
    1. Wilcock G, Möbius HJ, Stöffler A. A double-blind, placebo-controlled multicentre study of memantine in mild to moderate vascular dementia (MMM500). Int Clin Psychopharmacol 2002;17:297–305. 10.1097/00004850-200211000-00005
    1. Wilkinson D, Doody R, Helme R, et al. . Donepezil in vascular dementia: a randomized, placebo-controlled study. Neurology 2003;61:479–86. 10.1212/01.WNL.0000078943.50032.FC
    1. Liu-Ambrose T, Eng JJ, Boyd LA, et al. . Promotion of the mind through exercise (PROMoTE): a proof-of-concept randomized controlled trial of aerobic exercise training in older adults with vascular cognitive impairment. BMC Neurol 2010;10:14 10.1186/1471-2377-10-14
    1. Food and Drug Administration. Peripheral and central nervous system drugs advisory committee meeting. Rockville, MD: Department of Health and Human Services, Public Health Service, 1989:227.
    1. Schrag A, Schott JM. What is the clinically relevant change on the ADAS-Cog? J Neurol Neurosurg Psychiatry 2012;83:171–3. 10.1136/jnnp-2011-300881
    1. Portney LG, Watkins MP. Foundations of clinical research: applications to practice. Norwalk: Appleton and Lange, 1993.
    1. Dunnett C, Goldsmith C. When and how to decide to do multiple comparisons : Buncher CR, Tsay J-Y, Statistics in the pharmaceutical company. 3rd edn Boca Raton, FL: CRC Press, Taylor and Francis Group, 2006:421–51.
    1. Little RJ, D’Agostino R, Cohen ML, et al. . The prevention and treatment of missing data in clinical trials. N Engl J Med 2012;367:1355–60. 10.1056/NEJMsr1203730
    1. Drummond MF, Sculpher MJ, Torrance GW, et al. . Methods for the economic evaluation for health car programmes. 3rd edn New York: Oxford University Press, 2005.
    1. Glick HA, Doshi JA, Sonnad SA, et al. . Economic evaluation in clinical trials. 1st edn New York: Oxford University Press, 2007.
    1. Briggs AH, Gray AM. Handling uncertainty when performing economic evaluation of healthcare interventions. Health Technol Assess 1999;3:1–134.
    1. Oostenbrink JB, Al MJ, Rutten-van Mölken MP. Methods to analyse cost data of patients who withdraw in a clinical trial setting. Pharmacoeconomics 2003;21:1103–12. 10.2165/00019053-200321150-00004
    1. Thabane L, Ma J, Chu R, et al. . A tutorial on pilot studies: the what, why and how. BMC Med Res Methodol 2010;10:1 10.1186/1471-2288-10-1

Source: PubMed

Sponsoren und Mitarbeiter

Krankheiten

Drogeninterventionen

3
Abonnieren